Evidence map›Paper›PMID 37578659›Full record

ArticleCancer immunology, immunotherapy : CII2023

Correction to: Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer.

Jiannan Chen, Jianhua Hu, Lili Gu, Feng Ji, Fan Zhang, Miaomiao Zhang, Jun Li, Zhengliang Chen, Longwei Jiang, Yan Zhang and 9 more

Open access · bronzeAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Advances in CAR T Cell Therapy for Non-Small Cell Lung Cancer.Current issues in molecular biology · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Jiannan ChenJiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.
Jianhua HuDepartment of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
Lili GuJiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.
Feng JiJiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.
Fan ZhangJiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.
Miaomiao ZhangJiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.
Jun LiNanjing Blue Shield Biotechnology Co., Ltd., Nanjing, 210023, China.
Zhengliang ChenNanjing Blue Shield Biotechnology Co., Ltd., Nanjing, 210023, China.
Longwei JiangDepartment of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
Yan ZhangDepartment of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
Ruifang ShiDepartment of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
Lihua MaDepartment of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
Shaochang JiaDepartment of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
Ying ZhangDepartment of Pathology, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China.
Qi ZhangCenter of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China.
Junqing LiangInner Mongolia Autonomous Region Cancer Hospital, Hohhot, 010010, China.
Shunyu YaoBaylor University, 1311 S 5Th St, Waco, USA.
Zhigang HuJiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China. huzg_2000@126.com.
Zhigang GuoJiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China. guo@njnu.edu.cn.
Nanjing Normal University · CNNanjing General Hospital of Nanjing Military Command · CNNanjing University · CNBaylor University · USInner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine · CNZhongda Hospital Southeast University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37578659
PMCPMC10991345
OpenAlexW4385799112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.